Inventor
BLANEY JOSEPH E
US25 patents
⚠️ This page may combine multiple inventors who share the name “BLANEY JOSEPH E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
10 patentsUS8039003B2Oct 18, 2011
Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
US HEALTH8 citations92
US7560118B2Jul 14, 2009
Attenuated dengue virus comprising mutations in the NS3 gene
US HEALTH8 citations92
US7226602B2Jun 5, 2007
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
US HEALTH17 citations92
US10058602B2Aug 28, 2018
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH3 citations72
US11400150B2Aug 2, 2022
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations62
US11318196B2May 3, 2022
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
US HEALTH0 citations62
US10500264B2Dec 10, 2019
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
US HEALTH0 citations52
US10160957B2Dec 25, 2018
Development of dengue virus vaccine components
US HEALTH0 citations52
US10869920B2Dec 22, 2020
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations51
US10456461B2Oct 29, 2019
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations51
THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
4 patentsUS12203100B2Jan 21, 2025
Development of dengue virus vaccine components
THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations61
US11746335B2Sep 5, 2023
Development of dengue virus vaccine components
THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations61
US11332722B2May 17, 2022
Development of dengue virus vaccine components
THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations61
US10724007B2Jul 28, 2020
Development of dengue virus vaccine components
THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations51
US GOVERNMENT
2 patentsWHITEHEAD STEPHEN S
2 patentsTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
2 patentsUSRE46641EDec 19, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES5 citations83
USRE46631EDec 12, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES7 citations83
US OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES
2 patentsUS9090873B2Jul 28, 2015
Development of dengue virus vaccine components
US OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES5 citations83
USRE45016EJul 15, 2014
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
US OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES4 citations83